79508-09-1 Usage
Description
3-carbomethoxy-5-(4-chlorophenyl)pyrazole is a pyrazole derivative with the molecular formula C11H10ClN3O2. It features a carbomethoxy group and a 4-chlorophenyl group, and is often utilized in medicinal chemistry and pharmaceutical research as a potential therapeutic agent for the treatment of various diseases. Its unique structure and properties have made it a subject of scientific studies and research, highlighting its significant potential in drug development.
Uses
Used in Pharmaceutical Research:
3-carbomethoxy-5-(4-chlorophenyl)pyrazole is used as a potential therapeutic agent for the development of new drugs to treat a range of diseases. Its specific pharmacological properties and potential applications are under investigation in scientific studies and research, which recognize its promising role in drug development.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-carbomethoxy-5-(4-chlorophenyl)pyrazole is employed for its unique structure and properties, which contribute to its potential as a building block or active component in the creation of novel pharmaceutical compounds.
Used in Materials Science and Chemical Synthesis:
Beyond its applications in medicine, 3-carbomethoxy-5-(4-chlorophenyl)pyrazole may also find uses in other fields such as materials science and chemical synthesis, where its chemical properties could be leveraged for various purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 79508-09-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,5,0 and 8 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 79508-09:
(7*7)+(6*9)+(5*5)+(4*0)+(3*8)+(2*0)+(1*9)=161
161 % 10 = 1
So 79508-09-1 is a valid CAS Registry Number.
79508-09-1Relevant articles and documents
Design, synthesis, biological evaluation and in silico studies of pyrazole‐based nh2‐acyl oseltamivir analogues as potent neuraminidase inhibitors
Ye, Jiqing,Lin, Lin,Xu, Jinyi,Chan, Paul Kay-Sheung,Yang, Xiao,Ma, Cong
, (2021/05/05)
Oseltamivir represents one of the most successful neuraminidase (NA) inhibitors in the current anti‐influenza therapy. The 150‐cavity of NA was identified as an additional binding pocket, and novel NA inhibitors have been designed to occupy the 150‐cavity
Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation
Levent, Serkan,?ali?kan, Burcu,?ift?i, Murat,?zkan, Ye?im,Yenicesu, Idil,ünver, Hüseyin,Banoglu, Erden
, p. 42 - 53 (2013/07/27)
Antiplatelet drugs are promising therapeutics to intervene with platelet aggregation in arterial thrombosis, most prominently in myocardial infarction and ischemic stroke. Here, we describe the synthesis and structure-activity relationships of potent inhibitors of platelet aggregation based on the 1,5-diarylpyrazol-3-carboxamide scaffold. Analogs from this series demonstrated potent anti-aggregatory activities against arachidonic acid-induced platelet aggregation, as measured by turbidimetric method of Born. 1,5-Diarylpyrazole-3- carboxamides obtained with small-basic amines (7, 8, 50, 51, 61, 62) displayed the strongest activity with IC50 values in low nanomolar range (5.7-83 nM). On the basis of their high potency in cellular environment, these straightforward pyrazole derivatives may possess potential in the design of more potent compounds for intervention with cardiovascular diseases.
